Rationale and design of the Transformative Research in Diabetic Nephropathy (TRIDENT) Study

Kidney Int. 2020 Jan;97(1):10-13. doi: 10.1016/j.kint.2019.09.020.

TRIDENT Study Investigators:
Randy Luciano, Michael Ross, Pietro Canetta, Krik Campbell, Jonathan Hogan, Amy Mottl, Oliver Lenz, Harold Szerlip, Shweta Bansal, Chip Brosius, Jeffery Schelling, Salem Almaani, Matthias Kretzler, Tamara Isakova, Rupali Avasare, Richard Lafayette, Christos Argyropoulos

¹ Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Electronic address: townsend@upenn.edu.
² Cardiometabolic Disease Research Department, Boehringer Ingelheim, Ridgefield, Connecticut, USA.
³ Division of Nephrology, University of New Mexico School of Medicine, Albuquerque, New Mexico, USA.
⁴ Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
⁵ Cardiovascular, Renal and Fibrosis Research, Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA.
⁶ University of North Carolina Kidney Center, Chapel Hill, North Carolina, USA.
⁷ Inflammation & Respiratory Therapeutics, Gilead Sciences Inc., Foster City, California, USA.
⁸ Department of Pathology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
⁹ Division of Nephrology, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York, USA.
¹⁰ Department of Human Genetics, GlaxoSmithKline, Collegeville, Pennsylvania, USA.
¹¹ Office of Clinical Research, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
¹² Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

No abstract available

Keywords: diabetic nephropathy; gene expression; glomerulus; kidney biopsy.

Publication types